What is it about?

Combined Aphasia and Apraxia of Speech Treatment (CAAST) is an evidence-based treatment for individuals with both aphasia and apraxia of speech. This treatment targets response elaboration and sound production. This study sought to verify the efficacy of CAAST when administered via telehealth platforms.

Featured Image

Why is it important?

Telehealth became a much needed modality of treatment following the events of the COVID-19 pandemic. With telehealth's success, it is a medium which has continued to be employed. There are variables that arise when adding technology to a behavioral treatment and this study sought to confirm that CAAST was viable and efficacious via telehealth.

Perspectives

I am privileged to be part of this wonderful team and to work with our amazing participants. Being able to provide effective evidence-based treatment to those who may have travel or mobility barriers allows us to further the reach of the speech-language pathologist. In doing so we are afforded the opportunity to return the very human act of communication to those affected by communication disorders.

Daniel Salomon
University of Utah

Read the Original

This page is a summary of: The Outcomes of Remote Administration of Combined Aphasia and Apraxia of Speech Treatment: A Single-Subject Experimental Design Study, American Journal of Speech-Language Pathology, June 2023, American Speech-Language-Hearing Association (ASHA), DOI: 10.1044/2023_ajslp-22-00297.
You can read the full text:

Read

Contributors

The following have contributed to this page